Choate Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.76M	Sell	3,937 -39	-1%	-$18.2K	0.03%	180
2025 Q4	$1.8M	Sell	3,976 -15	-0.4%	-$6.46K	0.04%	170
2025 Q3	$1.56M	Sell	3,991 -311	-7%	-$130K	0.03%	169
2025 Q2	$1.92M	Sell	4,302 -183	-4%	-$84.3K	0.04%	147
2025 Q1	$2.17M	Buy	4,485 +19	+0.4%	+$8.85K	0.05%	130
2024 Q4	$1.8M	Buy	4,466 +154	+4%	+$71.4K	0.04%	145
2024 Q3	$2.01M	Sell	4,312 -301	-7%	-$145K	0.05%	141
2024 Q2	$2.16M	Sell	4,613 -442	-9%	-$192K	0.06%	128
2024 Q1	$2.11M	Sell	5,055 -10	-0.2%	-$4.23K	0.06%	139
2023 Q4	$2.06M	Buy	5,065 +1,611	+47%	+$595K	0.06%	125
2023 Q3	$1.2M	Buy	3,454 +1,132	+49%	+$396K	0.05%	139
2023 Q2	$817K	Buy	2,322 +257	+12%	+$86.6K	0.03%	161
2023 Q1	$651K	Hold	2,065	–	–	0.03%	160
2022 Q4	$596K	Buy	2,065 +113	+6%	+$34.4K	0.04%	166
2022 Q3	$565K	Hold	1,952	–	–	0.04%	146
2022 Q2	$550K	Buy	1,952 +649	+50%	+$174K	0.03%	160
2022 Q1	$340K	Buy	1,303 +64	+5%	+$15.2K	0.02%	234
2021 Q4	$272K	Hold	1,239	–	–	0.02%	244
2021 Q3	$225K	Sell	1,239 -812	-40%	-$159K	0.01%	249
2021 Q2	$414K	Buy	2,051 +805	+65%	+$168K	0.03%	193
2021 Q1	$268K	Buy	+1,246	New	+$274K	0.02%	229